Metabolic Disorders

PATIENT ACCESS

Metabolic Disease

Hyperlipidemia
Dyslipidemia (cholesterol and triglycerides)
Hypertension

Diabetes

T1DM and T2DM (including metformin)
T1DM/T2DM + Nephropathy or Fatty Liver

Obesity

Obesity with BMI of 30 to >40
Stratified by sex, age, and gender

CLINIC CAPABILITIES

Our patient-centric facility with 24/7 medical oversight provides the perfect location for conducting studies on metabolic disorders.

50+ Phase I to III Studies

Efficacy and Long-term safety
BA/BE, PK/PD and POC
SAD/MAD and Adaptive Designs
Clamping techniques
Ability to support multiple ROAs (oral, sub-lingual, IV, nasal, subcutaneous, intramuscular, parenteral, inhalation, infusion)
OGTT: Oral Glucose Tolerance Test with indirect calorimetry
Biomarker testing with Pacific Biomarkers and other providers

CASE STUDIES

Come and join us at one of our upcoming events!

Successful enrollment of 100+ T2DM Patients for a 21-day inpatient stay

Successful enrollment of 60 Obese Subjects in a Phase 1 Study with Moderate Dyslipidemia

Bioavailability, Tolerability and Safety Study

Phase 1 comparability Study to assess subcutaneous PD and PK

Phase 1 Single/Multiple Dose Study to Assess Safety, Tolerability and Pharmacokinetics in Subjects with Type 2 Diabetes Mellitus

Phase 3 LDL-C lowering evaluation in Patients with Primary Hyperlipidemia